Surrogacy in Saudi Arabia: the legal framework
Short answer
On the statutory rules reviewed, surrogacy is not a lawful treatment model to carry out through a Saudi Arabian fertilization, embryo or infertility-treatment unit when it involves placing a fertilized egg from a married couple into another woman’s womb. Article 5 of the Law of Fertilization, Utero-Fetal and Infertility Treatment Units expressly says that a fertilized egg must not be implanted in the womb of another wife or another woman. The same article also prohibits insemination with sperm other than the woman’s husband and fertilization of an egg other than the wife’s.
The rule contains no exception based on whether the arrangement is paid or unpaid. Accordingly, calling a programme “altruistic”, using a relative as the carrier, reimbursing expenses, or signing a private agreement does not remove the statutory prohibition on the medical procedure itself. This is a conclusion about the reproductive procedure addressed by the law, not a blanket conclusion that every conversation, payment, contract, intermediary service or foreign surrogacy arrangement is independently criminal or automatically void.
This guide focuses on domestic Saudi law and the rules governing medical treatment units. It does not determine parentage, nationality, birth registration, passport or travel outcomes after a programme abroad. Those are separate questions and should be reviewed before anyone signs, pays or begins treatment.
Which rules control?
The principal instrument is the Law of Fertilization, Utero-Fetal and Infertility Treatment Units, approved by Royal Decree No. M/76 in 1424H (2004). The indexed listing for the official Bureau of Experts record identifies the law as in force, but direct retrieval of the record was intermittent during this check. The Saudi Ministry of Health publishes official English texts of the law and implementing regulations, including Articles 5 and 32.
Article 3 requires fertility-treatment units to comply with fatwas issued by the Council of Senior Ulama in the Kingdom. A careful analysis therefore distinguishes the statute, its implementing regulations, relevant fatwas incorporated by Article 3, supervisory or licensing decisions, a clinic’s own policy, and a private contract. These are not interchangeable sources. The central conclusion here does not depend on search demand, clinic advertising or a general assumption about religious doctrine: Article 5 itself states the medical restriction.
The statutory text does not resolve every private-contract or cross-border issue. If the outcome turns on a particular fatwa, later administrative decision or court ruling, Saudi counsel should verify the exact text and its application to the facts.
The direct prohibition on gestational surrogacy
Article 5 says that a fertilized egg from a married couple may not be implanted in the womb of another wife or another woman. In a typical gestational-surrogacy plan, an embryo created from the wife’s egg and her husband’s sperm is transferred to a woman other than that wife, who will carry the pregnancy. That is the procedure the statutory wording directly addresses. The prohibition is not written as a rule that applies only when the carrier is paid, unrelated to the intended parents, or acting through a commercial agency.
The legal focus is the proposed medical act and the identity of the gestational recipient, not the label chosen by the parties. A family arrangement, friendship, expense-only arrangement or “compassionate” description does not create an exception in Article 5. Nor does consent from the carrier and intended parents override a statutory restriction. Written consent is required for permitted fertility treatment, but consent is not a licence to perform a prohibited procedure.
This conclusion concerns treatment carried out under Saudi Arabia’s assisted-reproduction framework. It should not be stretched into an unsupported claim about the legal status of every private discussion, an arrangement formed abroad, or a person’s parental status after a foreign birth. Those questions require separate rules and facts.
Commercial, altruistic and traditional arrangements
The law does not create separate permitted and prohibited categories based on the surrogate’s fee. Instead, Article 5 sets a medical restriction and does not provide a compensation-based exception. The distinction between the medical procedure and the surrounding private arrangement matters:
The following matrix summarises what the reviewed Saudi assisted-reproduction provisions do—and do not—establish.
| Scenario | Rule in the reviewed Saudi law | Practical meaning |
|---|---|---|
| Embryo from a married couple is implanted in another woman | Article 5 expressly prohibits implantation in another wife’s or another woman’s womb. | Gestational surrogacy cannot be treated as a permitted Saudi fertility-unit procedure. |
| Traditional arrangement using the intended father’s sperm to inseminate another woman | Article 5 separately prohibits insemination with sperm other than that woman’s husband and fertilization of an egg other than the wife’s. | Do not assume that changing the technique avoids the statutory restrictions. |
| Carrier receives no fee, is a relative, or receives expense reimbursement | Article 5 contains no exception tied to payment, relationship or altruistic motive. | The no-fee label does not remove the embryo-transfer prohibition. |
| Private contract, agency commission or payment dispute | The reviewed provisions do not independently resolve every contract or payment issue. | A separate Saudi-law analysis is needed; a contract cannot authorize a prohibited medical act. |
| Programme performed outside Saudi Arabia | The domestic ART law does not itself decide foreign parentage recognition, nationality or travel documents. | Review the law of the treatment/birth country and the Saudi consequences separately. |
Potential penalties under Article 32
Article 32 provides that a person who commits one of the listed violations may receive one or more of these penalties: a fine of not less than SAR 200,000 and not more than SAR 500,000; imprisonment for up to five years; and revocation of a professional licence. The article expressly lists transferring a woman’s zygotes or embryos to the womb of another woman. It also lists, among other violations, fertility treatment without a licence or beyond the licensed level, injecting sperm or embryos into a woman from someone other than her husband, and treatment after the marital relationship has ended. The law preserves the possibility of a more severe penalty under another law.
These are statutory maximums and ranges, not an automatic sentence in every case. The authority must assess the conduct, evidence, responsible persons and applicable procedure. The text does not support a categorical statement that every intended parent, carrier, adviser, agent or person who reimburses expenses will necessarily receive the same penalty. The professional-licence sanction is especially relevant to a person or provider who holds such a licence; its application depends on the respondent and the decision made.
Article 33 separately allows one or more of the following for other proven violations of the law or its implementing regulations, excluding the violations specifically listed in Article 32: a warning; a fine from SAR 20,000 to SAR 200,000; imprisonment for up to two years; or professional-licence revocation. Do not automatically apply Article 33 to a surrogacy fact pattern without identifying the actual alleged violation. For any real case, obtain advice on the precise conduct, participants and enforcement position.
What fertility treatment can be permitted?
Article 1 defines infertility as the inability to conceive after more than 12 months of unprotected intercourse while a marital relationship exists. Under Article 2, medical intervention may be used where infertility results from reduced fertility or a treatable medical condition, on the basis of a medical report; procedures to treat infertility established as incurable are prohibited. Implementing Regulation 2/1 further requires a report from a Ministry-licensed unit or centre addressing the diagnosis and whether intervention is permissible. These eligibility rules govern ordinary infertility treatment and do not override Article 5’s limits on the source of gametes or the woman who may receive the embryo.
Article 4 requires proof of a subsisting marriage before treatment and prohibits fertilizing the wife’s egg with the husband’s sperm after divorce or the husband’s death. Implementing Regulation 4/2 provides a narrow written-fatwa qualification for the husband’s death; after divorce or a marital dispute, the physician must not continue fertilization or artificial insemination at either spouse’s request. The precise application should be checked against the authoritative Arabic text and any case-specific written fatwa. Article 5 separately limits whose sperm and egg may be used and prohibits implanting a fertilized egg in another woman. Taken together, these provisions describe regulated fertility treatment for spouses—not donor conception or embryo transfer to another woman.
The fact that a couple qualifies for a lawful IVF or other fertility procedure does not mean that every proposed use of the resulting embryo is lawful. Eligibility for treatment, the permitted source of gametes, the timing of treatment and the identity of the woman receiving the embryo are distinct legal checks.
Clinic licensing, consent and treatment records
Article 6 requires explicit written consent from both spouses after they have been informed about the treatment method, procedures, risks and possible outcomes. Article 19 states that a fertility, embryo and infertility-treatment unit may not be established or operated without a Ministry of Health licence based on a recommendation from the Supervisory Committee. Article 20 provides for licensed service levels, ranging from ovulation-induction treatment and artificial insemination to IVF, ICSI and micromanipulation, subject to the applicable rules.
Article 32 treats practice without a licence, or at a level other than the licensed one, as a serious violation. A licence authorizes only the service scope granted to that unit; it does not waive Article 5 or make an otherwise prohibited embryo transfer permissible. A clinic’s website, a sales representative’s assurance, a draft contract or a foreign agency’s promise is not a legal exception.
If assessing a provider for a lawful fertility procedure, ask for its current licence, the authorized service level, a written treatment plan, the source and identity of the gametes, the proposed recipient of any embryo, the consent forms and a breakdown of costs. These checks help establish what is actually proposed. They cannot convert a prohibited surrogacy procedure into a permitted one.
Contracts, compensation and intermediaries
The provisions discussed above primarily regulate medical treatment and the conduct of licensed units. They do not independently answer every question about a private surrogacy agreement, a reimbursement promise, an agency commission, advertising, repayment after a clinic refuses treatment, damages, or the civil consequences of a failed arrangement. It would therefore be inaccurate to say, based only on Article 5, that every payment or every private contract is a separately defined criminal offence—or that such a contract is enforceable.
What can be said safely is narrower: private consent, compensation, a relative’s involvement or an agency’s fee cannot authorize the embryo-transfer procedure that Article 5 prohibits. Calling payment “expenses”, “consulting”, “coordination” or a donation does not change the medical act. Whether a particular payment arrangement triggers other legal consequences depends on the contract, the parties, the services actually supplied and any other applicable Saudi rules.
Before signing or paying, obtain independent Saudi legal advice—not only advice from the clinic or intermediary. The review should identify each party, the place and method of treatment, what the payment covers, what happens if the procedure is refused, and what remedies may be available. Do not assume that a clinic’s willingness to accept money proves that the arrangement is lawful.
If the programme is abroad
This article addresses the domestic Saudi framework for assisted-reproduction units and the medical procedure carried out in Saudi Arabia. The cited provisions do not, by themselves, determine whether Saudi authorities will recognize an overseas birth certificate, a foreign court order, the intended parents’ status, or the surrogate’s status after a foreign birth. They also do not settle nationality, passport issuance, consular documentation, visa, exit or re-entry questions.
Conversely, the fact that another country permits commercial or altruistic surrogacy does not make the same procedure lawful in Saudi Arabia and does not guarantee that Saudi authorities will recognize the resulting documents or parentage. A cross-border plan requires separate analysis of at least the law of the place where treatment occurs, the law of the place of birth, the law governing the intended parents’ nationality or residence, and any Saudi recognition or registration step actually needed.
Before committing to an overseas programme, obtain written advice that addresses both the foreign procedure and the intended legal outcome in Saudi Arabia. Do not treat a foreign clinic’s licence, a local birth certificate or an agency’s marketing statement as proof of Saudi recognition. Parentage, citizenship and travel are separate issues from whether the medical procedure is permitted where it takes place.
Practical next steps
Before proceeding, use this decision sequence: (1) identify exactly where the fertility treatment and embryo transfer will occur; (2) obtain a written description of the proposed procedure, the source of the egg and sperm, and the identity of the woman who would carry the pregnancy; (3) compare those facts with Article 5, especially its prohibition on implantation in another woman’s womb; (4) do not rely on whether the carrier is paid, related to the intended parents, or described as altruistic; (5) verify the clinic’s current licence and authorized service level for any lawful fertility treatment; and (6) consult an independent Saudi lawyer about the exact facts, contract, potential penalties and any other applicable law.
If a programme is planned abroad, separately verify the law in the treatment and birth countries and obtain advice on the intended parents’ nationality, parentage recognition, registration and travel steps before making an irreversible commitment. These questions are not answered by Article 5 alone.
If treatment or a transfer has already begun, preserve contracts, invoices, messages, medical records and consent forms. Do not delete, alter or backdate records. Obtain confidential legal advice promptly before taking another legal or contractual step. If a pregnancy or urgent medical need is involved, continue to use qualified medical care; legal review should not delay necessary treatment.
Primary legal sources
The Bureau of Experts page intermittently failed to load; the operative provisions were cross-checked against the Ministry of Health official text.
- S1. Saudi Bureau of Experts at the Council of Ministers — Law of Fertilization, Utero-Fetal and Infertility Treatment Units (official Arabic law record) — Official Arabic law record; its indexed text identifies the law as in force and contains Articles 5 and 32.
- S2. Saudi Ministry of Health — Law of Fertilization, Utero-Fetal and Infertility Treatment Units (official English text) — Official English text of the law; includes Articles 2–7, 19–20 and 32–33.
- S3. Saudi Ministry of Health — Amendment of the Implementing Regulations of the Law of Fertilization, Utero-Fetal and Infertility Treatment Units (official English PDF) — Official Ministry PDF containing implementing regulations and amendments relevant to the treatment-unit framework.








